RAPT Therapeutics (RAPT) Shares Outstanding (Weighted Average) (2021 - 2024)
Historic Shares Outstanding (Weighted Average) for Therapeutics (RAPT) over the last 4 years, with Q3 2024 value amounting to $38.9 million.
- Therapeutics' Shares Outstanding (Weighted Average) rose 142.2% to $38.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $38.9 million, marking a year-over-year increase of 142.2%. This contributed to the annual value of $38.3 million for FY2023, which is 1781.71% up from last year.
- According to the latest figures from Q3 2024, Therapeutics' Shares Outstanding (Weighted Average) is $38.9 million, which was up 142.2% from $38.9 million recorded in Q2 2024.
- Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $38.9 million during Q3 2024, with a 5-year trough of $24.8 million in Q1 2021.
- For the 4-year period, Therapeutics' Shares Outstanding (Weighted Average) averaged around $33.6 million, with its median value being $33.7 million (2022).
- As far as peak fluctuations go, Therapeutics' Shares Outstanding (Weighted Average) skyrocketed by 2944.66% in 2023, and later soared by 90.08% in 2024.
- Over the past 4 years, Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $27.4 million in 2021, then grew by 18.8% to $32.5 million in 2022, then increased by 17.82% to $38.3 million in 2023, then increased by 1.47% to $38.9 million in 2024.
- Its Shares Outstanding (Weighted Average) stands at $38.9 million for Q3 2024, versus $38.9 million for Q2 2024 and $38.6 million for Q1 2024.